About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Blood Group Typing Market Size, Demand, Top Share, Forecast to 2031
Blood Group Typing Market

Blood Group Typing Market Size, Share & Trends Analysis Report By Techniques (PCR-Based and Microarray Technique, Massively Parallel Sequencing, Assay-based Techniques, Others), By Test Type (Human Leukocyte Antigen (HLA) Typing, Antibody Screening, ABO Blood Tests, Cross-matching Series, Antigen Typing), By Products Type (Instruments, Services, Consumables), By End-User (Clinical Laboratories, Blood Banks, Hospitals, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54582DR
Last Updated : December 20, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Blood Group Typing Market Introduction
    2. By Techniques
      1. Introduction
        1. Techniques By Value
      2. PCR-Based and Microarray Technique
        1. By Value
      3. Massively Parallel Sequencing
        1. By Value
      4. Assay-based Techniques
        1. By Value
      5. Others
        1. By Value
    3. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      3. Antibody Screening
        1. By Value
      4. ABO Blood Tests
        1. By Value
      5. Cross-matching Series
        1. By Value
      6. Antigen Typing
        1. By Value
    4. By Products Type
      1. Introduction
        1. Products Type By Value
      2. Instruments
        1. By Value
      3. Services
        1. By Value
      4. Consumables
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Laboratories
        1. By Value
      3. Blood Banks
        1. By Value
      4. Hospitals
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Techniques
      1. Introduction
        1. Techniques By Value
      2. PCR-Based and Microarray Technique
        1. By Value
      3. Massively Parallel Sequencing
        1. By Value
      4. Assay-based Techniques
        1. By Value
      5. Others
        1. By Value
    3. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      3. Antibody Screening
        1. By Value
      4. ABO Blood Tests
        1. By Value
      5. Cross-matching Series
        1. By Value
      6. Antigen Typing
        1. By Value
    4. By Products Type
      1. Introduction
        1. Products Type By Value
      2. Instruments
        1. By Value
      3. Services
        1. By Value
      4. Consumables
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Laboratories
        1. By Value
      3. Blood Banks
        1. By Value
      4. Hospitals
        1. By Value
      5. Others
        1. By Value
    6. U.S.
      1. By Techniques
        1. Introduction
          1. Techniques By Value
        2. PCR-Based and Microarray Technique
          1. By Value
        3. Massively Parallel Sequencing
          1. By Value
        4. Assay-based Techniques
          1. By Value
        5. Others
          1. By Value
      2. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        3. Antibody Screening
          1. By Value
        4. ABO Blood Tests
          1. By Value
        5. Cross-matching Series
          1. By Value
        6. Antigen Typing
          1. By Value
      3. By Products Type
        1. Introduction
          1. Products Type By Value
        2. Instruments
          1. By Value
        3. Services
          1. By Value
        4. Consumables
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Laboratories
          1. By Value
        3. Blood Banks
          1. By Value
        4. Hospitals
          1. By Value
        5. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Techniques
      1. Introduction
        1. Techniques By Value
      2. PCR-Based and Microarray Technique
        1. By Value
      3. Massively Parallel Sequencing
        1. By Value
      4. Assay-based Techniques
        1. By Value
      5. Others
        1. By Value
    3. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      3. Antibody Screening
        1. By Value
      4. ABO Blood Tests
        1. By Value
      5. Cross-matching Series
        1. By Value
      6. Antigen Typing
        1. By Value
    4. By Products Type
      1. Introduction
        1. Products Type By Value
      2. Instruments
        1. By Value
      3. Services
        1. By Value
      4. Consumables
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Laboratories
        1. By Value
      3. Blood Banks
        1. By Value
      4. Hospitals
        1. By Value
      5. Others
        1. By Value
    6. U.K.
      1. By Techniques
        1. Introduction
          1. Techniques By Value
        2. PCR-Based and Microarray Technique
          1. By Value
        3. Massively Parallel Sequencing
          1. By Value
        4. Assay-based Techniques
          1. By Value
        5. Others
          1. By Value
      2. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        3. Antibody Screening
          1. By Value
        4. ABO Blood Tests
          1. By Value
        5. Cross-matching Series
          1. By Value
        6. Antigen Typing
          1. By Value
      3. By Products Type
        1. Introduction
          1. Products Type By Value
        2. Instruments
          1. By Value
        3. Services
          1. By Value
        4. Consumables
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Laboratories
          1. By Value
        3. Blood Banks
          1. By Value
        4. Hospitals
          1. By Value
        5. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Techniques
      1. Introduction
        1. Techniques By Value
      2. PCR-Based and Microarray Technique
        1. By Value
      3. Massively Parallel Sequencing
        1. By Value
      4. Assay-based Techniques
        1. By Value
      5. Others
        1. By Value
    3. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      3. Antibody Screening
        1. By Value
      4. ABO Blood Tests
        1. By Value
      5. Cross-matching Series
        1. By Value
      6. Antigen Typing
        1. By Value
    4. By Products Type
      1. Introduction
        1. Products Type By Value
      2. Instruments
        1. By Value
      3. Services
        1. By Value
      4. Consumables
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Laboratories
        1. By Value
      3. Blood Banks
        1. By Value
      4. Hospitals
        1. By Value
      5. Others
        1. By Value
    6. China
      1. By Techniques
        1. Introduction
          1. Techniques By Value
        2. PCR-Based and Microarray Technique
          1. By Value
        3. Massively Parallel Sequencing
          1. By Value
        4. Assay-based Techniques
          1. By Value
        5. Others
          1. By Value
      2. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        3. Antibody Screening
          1. By Value
        4. ABO Blood Tests
          1. By Value
        5. Cross-matching Series
          1. By Value
        6. Antigen Typing
          1. By Value
      3. By Products Type
        1. Introduction
          1. Products Type By Value
        2. Instruments
          1. By Value
        3. Services
          1. By Value
        4. Consumables
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Laboratories
          1. By Value
        3. Blood Banks
          1. By Value
        4. Hospitals
          1. By Value
        5. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Techniques
      1. Introduction
        1. Techniques By Value
      2. PCR-Based and Microarray Technique
        1. By Value
      3. Massively Parallel Sequencing
        1. By Value
      4. Assay-based Techniques
        1. By Value
      5. Others
        1. By Value
    3. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      3. Antibody Screening
        1. By Value
      4. ABO Blood Tests
        1. By Value
      5. Cross-matching Series
        1. By Value
      6. Antigen Typing
        1. By Value
    4. By Products Type
      1. Introduction
        1. Products Type By Value
      2. Instruments
        1. By Value
      3. Services
        1. By Value
      4. Consumables
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Laboratories
        1. By Value
      3. Blood Banks
        1. By Value
      4. Hospitals
        1. By Value
      5. Others
        1. By Value
    6. UAE
      1. By Techniques
        1. Introduction
          1. Techniques By Value
        2. PCR-Based and Microarray Technique
          1. By Value
        3. Massively Parallel Sequencing
          1. By Value
        4. Assay-based Techniques
          1. By Value
        5. Others
          1. By Value
      2. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        3. Antibody Screening
          1. By Value
        4. ABO Blood Tests
          1. By Value
        5. Cross-matching Series
          1. By Value
        6. Antigen Typing
          1. By Value
      3. By Products Type
        1. Introduction
          1. Products Type By Value
        2. Instruments
          1. By Value
        3. Services
          1. By Value
        4. Consumables
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Laboratories
          1. By Value
        3. Blood Banks
          1. By Value
        4. Hospitals
          1. By Value
        5. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Techniques
      1. Introduction
        1. Techniques By Value
      2. PCR-Based and Microarray Technique
        1. By Value
      3. Massively Parallel Sequencing
        1. By Value
      4. Assay-based Techniques
        1. By Value
      5. Others
        1. By Value
    3. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      3. Antibody Screening
        1. By Value
      4. ABO Blood Tests
        1. By Value
      5. Cross-matching Series
        1. By Value
      6. Antigen Typing
        1. By Value
    4. By Products Type
      1. Introduction
        1. Products Type By Value
      2. Instruments
        1. By Value
      3. Services
        1. By Value
      4. Consumables
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Laboratories
        1. By Value
      3. Blood Banks
        1. By Value
      4. Hospitals
        1. By Value
      5. Others
        1. By Value
    6. Brazil
      1. By Techniques
        1. Introduction
          1. Techniques By Value
        2. PCR-Based and Microarray Technique
          1. By Value
        3. Massively Parallel Sequencing
          1. By Value
        4. Assay-based Techniques
          1. By Value
        5. Others
          1. By Value
      2. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        3. Antibody Screening
          1. By Value
        4. ABO Blood Tests
          1. By Value
        5. Cross-matching Series
          1. By Value
        6. Antigen Typing
          1. By Value
      3. By Products Type
        1. Introduction
          1. Products Type By Value
        2. Instruments
          1. By Value
        3. Services
          1. By Value
        4. Consumables
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Laboratories
          1. By Value
        3. Blood Banks
          1. By Value
        4. Hospitals
          1. By Value
        5. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Blood Group Typing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Quotient Limited
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Immucor Inc.
    3. Merck KGaA
    4. The Novacyt Group
    5. Agena Bioscience Inc.
    6. BAG Diagnostics Gmbh
    7. AXO Science
    8. Rapid Labs Limited
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
Buy Now
Global Report
The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.